非类固醇抗炎药物是否会增加脑外科手术头骨切割后出血的风险? 一个系统的审查和元分析
Leonardo Januário Campos Cardoso1, Márcio Yuri Ferreira2, Isabela Coutinho Faria3
1Department of Medicine, Federal University of Minas Gerais, Belo Horizonte , Minas Gerais , Brazil.
Neurosurgery
|June 2, 2025
概括
非类固醇抗炎药物 (NSAIDs) 对于脑部手术后的疼痛缓解是安全的. 这项研究发现,与其他疼痛管理选择相比,使用NSAIDs时没有增加出血并发症的风险.
科学领域:
- 神经外科 神经外科
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 非类固醇抗炎药物 (NSAIDs) 经常用于切术患者的疼痛治疗.
- 存在关于NSAID安全性的担忧,特别是由于循环氧基酶抑制导致术后出血增加的可能性.
研究的目的:
- 评估在接受NSAID与非NSAID止痛药或安慰剂治疗的患者在进行脑部手术后发生出血并发症的风险.
主要方法:
- 在主要数据库 (PubMed,Scopus,Web of Science,Cochrane) 进行了系统的文献搜索.
- 包括比较NSAIDs与非NSAIDs用于术后疼痛缓解术后骨切割的研究.
- 主要终点是所有出血并发症和需要手术干预的;亚分析包括随机对照试验 (RCT) 和瘤切除.
主要成果:
- 分析了7项涉及2251名患者的研究 (5项RCT).
- 在NSAID和非NSAID组之间没有发现整体出血并发症的统计学上显著差异 (RR: 1.05;95% CI: 0.58,1.93).
- 同样,没有观察到需要手术干预的出血并发症的显著增加 (RR:1.27;95% CI:0.51,3.16).
结论:
- 无抗炎药似乎是进行切术的患者安全的止痛选择.
- 与非NSAID替代品相比,NSAIDs的使用不会显著增加术后出血并发症的风险.
相关概念视频
Aneurysm IV: Nursing Management
392
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
392
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Epistaxis
519
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
519


